SCHEMBL20132409

SCHEMBL20132409

COC(=O)c1ccc(NC2c3ccccc3-c3ccccc32)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
GABRA1 P14867 3/20 0.41
GABRG2 P18507 3/20 0.41
GABRB3 P28472 3/20 0.41
GABRA5 P31644 3/20 0.41
GABRA3 P34903 3/20 0.41
GABRA2 P47869 3/20 0.41
KDM4E B2RXH2 3/20 0.41
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRB2 P47870 2/20 0.41
GABRA4 P48169 2/20 0.41
GABRE P78334 2/20 0.41
GABRA6 Q16445 2/20 0.41
GABRG1 Q8N1C3 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20132408 0.82 HDAC3 (0.59) HDAC3HDAC1HDAC2HDAC6KDM4E
SCHEMBL20160948 0.75 HDAC3 (0.42) HDAC3HDAC1HDAC2HDAC6LMNA
SCHEMBL22031779 0.73 MAPK1 (0.62) MAPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL25501688 0.72 GABRA1 (0.62) MAPK1GABRA1GABRG2GABRB3GABRA5
Hydrochloric Acid SCHEMBL22031814 0.71 MAPK1 (0.61) MAPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL29260502 0.71 MAPK1 (0.61) MAPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL5972249 0.71 GABRP (0.45) MAPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL19794412 0.71 MAPK1 (0.56) MAPK1GABRA1GABRG2GABRB3GABRA5
SCHEMBL31598929 0.70 MAPK1 (0.59) MAPK1KDM4EALDH1A1LMNACYP1A2
SCHEMBL11390294 0.70 MAPK1 (0.59) MAPK1KDM4EALDH1A1MAPTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538084-B1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS INC (US) 2023-11-01 EP disclosed
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2021-02-23 US disclosed
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids ACETYLON PHARMACEUTICALS, INC. (US) 2019-08-06 US disclosed
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS ACETYLON PHARMACEUTICALS, INC. 2018-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10370324-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 MAPK1 2026/4885HDAC3 4/4885HDAC1 2/4885
US-10927072-B2 Phenyl and pyridinyl hydroxamic acids HDAC6, HDAC1, HDAC5 MAPK1 2026/4885HDAC3 4/4885HDAC1 2/4885
US-20180127356-A1 PHENYL AND PYRIDINYL HYDROXAMIC ACIDS HDAC6, HDAC1, HDAC5 MAPK1 2026/4885HDAC3 4/4885HDAC1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.